Liquid biopsies in lung cancer-time to implement research technologies in routine care?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

1. Beyond traditional biopsies: the emerging role of ctDNA and MRD on breast cancer diagnosis and treatment.Discover oncology · 2025
   Review
2. Current Issues of Next-Generation Sequencing-Based Circulating Tumor DNA Analysis in Colorectal Cancer.South Asian journal of cancer · 2024
   Review
3. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies.Cancers · 2024
   Review
4. Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer.Cancers · 2023
   Review
5. Clinical Circulating Tumor DNA Testing for Precision Oncology.Cancer research and treatment · 2023
   Article
6. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer.Exploration of targeted anti-tumor therapy · 2023
   Review
7. Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience.Biomedicines · 2021
   Article
8. Liquid Biopsy Applications in the Clinic.Molecular diagnosis & therapy · 2020
   Review
9. Results of Liquid Biopsy Studies by Next Generation Sequencing in Patients with Advanced Stage Non-small Cell Lung Cancer: Single Center Experience from Turkey.Balkan journal of medical genetics : BJMG · 2019
   Article
10. Next-generation sequencing in liquid biopsy: cancer screening and early detection.Human genomics · 2019
    Review
11. [Applicable Value of AMSS-PCR in Lung Cancer Gene Mutation Detection].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018
    Article
12. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.Cancer science · 2018
    Article
13. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.Current oncology reports · 2018
    Review
14. Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology.Cancers · 2017
    Review
15. Looking for sputum biomarkers in lung cancer secondary prevention: where are we now?Journal of thoracic disease · 2017
    Article
16. Cancer diagnostics: current concepts and future perspectives.Annals of translational medicine · 2017
    Article
17. Adaptive Control of Tumor Growth.Cancer control : journal of the Moffitt Cancer Center
    Review
18. Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases.Advances in radiation oncology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as